2 completed, 2 recruiting, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Neurodegenerative Disease, Hereditary: new trials by email Literature Review of Neurodegenerative Disease, Hereditary trials Research Report on Neurodegenerative Disease, Hereditary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment Lenalidomide 10 mg - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Not yet recruiting | St. Joseph's Hospital and Medical Center, Phoenix | 45 | 2025-06-01 | 2025-05-18 |
| A Phase 3 Study of NTLA-2001 in ATTRv-PN nexiguran ziclumeran, Normal Saline as Placebo - Neuromuscular Disease, Neuromuscular Diseases (NMD) | Phase 3 | Recruiting | Intellia Therapeutics | 60 | 2024-11-22 | 2026-04-16 |
| Molecular and Functional Imaging in Monogenic PD. Positron Emission Tomography (PET) scan using DASB tracer - Parkinson Disease, Nervous System Disorder | Recruiting | University of Exeter | 45 | 2022-07-01 | 2025-10-07 | |
| Natural History Study of FDXR Mutation-related Mitochondriopathy Mutation analysis - Neurodegenerative Disease, Hereditary, Mitochondrial Diseases | Completed | State University of New York at Buffalo | 33 | 2020-11-03 | 2024-03-08 | |
| Natural History Study of SLC25A46 Mutation-related Mitochondriopathy Mutation analysis - Neurodegenerative Disease, Hereditary, Mitochondrial Diseases | Completed | State University of New York at Buffalo | 9 | 2020-11-03 | 2024-03-08 |
Heredodegenerative Disorders, Nervous System (5) · Mitochondrial Diseases (2) · Nerve Degeneration (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Optic Atrophy (2) · Alzheimer Disease (1) · Amyloid Neuropathies (1) · Amyloid Neuropathies, Familial (1) · Amyloidosis (1) · Amyloidosis, Familial (1) · Amyloidosis, Hereditary, Transthyretin-Related (1) · Cognitive Dysfunction (1) · Encephalitis (1) · Genetic Diseases, Inborn (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (4) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Metabolic Diseases (2) · Optic Nerve Diseases (2) · Pathologic Processes (2) · Basal Ganglia Diseases (1) · Cognition Disorders (1)
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Lenalidomide (1) · Magnetic Resonance Spectroscopy (1) · NTLA-2001 (1) · Saline Solution (1) · Spinal Puncture (1)
State University of New York at Buffalo (2) · Intellia Therapeutics (1) · St. Joseph's Hospital and Medical Center, Phoenix (1) · University of Exeter (1)
United States (2) · Argentina (1) · Brazil (1) · Mexico (1) · Singapore (1) · Taiwan (1) · Thailand (1) · United Kingdom (1)
Taosheng Huang (2) · Marios Politits, Professor (1)